000 01493 a2200457 4500
005 20250513101441.0
264 0 _c19970602
008 199706s 0 0 eng d
022 _a0105-1873
024 7 _a10.1111/j.1600-0536.1996.tb02170.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndersen, K E
245 0 0 _aReproducibility of the chamber scarification test.
_h[electronic resource]
260 _bContact dermatitis
_cMar 1996
300 _a181-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents, Local
650 0 4 _aChlorhexidine
_xanalogs & derivatives
650 0 4 _aDermatitis, Irritant
_xdiagnosis
650 0 4 _aDermatologic Agents
_xadverse effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aForearm
650 0 4 _aHumans
650 0 4 _aIrritants
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOintments
650 0 4 _aOutcome Assessment, Health Care
650 0 4 _aParaffin
650 0 4 _aPatch Tests
_xmethods
650 0 4 _aPredictive Value of Tests
650 0 4 _aReproducibility of Results
650 0 4 _aSkin
_xdrug effects
650 0 4 _aTime Factors
773 0 _tContact dermatitis
_gvol. 34
_gno. 3
_gp. 181-4
856 4 0 _uhttps://doi.org/10.1111/j.1600-0536.1996.tb02170.x
_zAvailable from publisher's website
999 _c8827661
_d8827661